Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.

Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group..

Acta Diabetol. 2016 Oct 7. [Epub ahead of print]

PMID:
27718051
2.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

Rambaldi A, Grassi A, Masciulli A, Boschini C, Micò MC, Busca A, Bruno B, Cavattoni I, Santarone S, Raimondi R, Montanari M, Milone G, Chiusolo P, Pastore D, Guidi S, Patriarca F, Risitano AM, Saporiti G, Pini M, Terruzzi E, Arcese W, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Alessandrino EP, Torelli GF, Scimè R, Mordini N, Oldani E, Marfisi RM, Bacigalupo A, Bosi A.

Lancet Oncol. 2015 Nov;16(15):1525-36. doi: 10.1016/S1470-2045(15)00200-4.

PMID:
26429297
3.

Regular wine consumption in chronic heart failure: impact on outcomes, quality of life, and circulating biomarkers.

Cosmi F, Di Giulio P, Masson S, Finzi A, Marfisi RM, Cosmi D, Scarano M, Tognoni G, Maggioni AP, Porcu M, Boni S, Cutrupi G, Tavazzi L, Latini R; GISSI-HF Investigators..

Circ Heart Fail. 2015 May;8(3):428-37. doi: 10.1161/CIRCHEARTFAILURE.114.002091.

4.

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.

Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R, Tognoni G, Athyros VG, Ray KK, Gotto AM, Clearfield MB, Downs JR, McMurray JJ.

Eur Heart J. 2015 Jun 21;36(24):1536-46. doi: 10.1093/eurheartj/ehv072. Review.

5.

Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.

Bassan R, Masciulli A, Intermesoli T, Audisio E, Rossi G, Pogliani EM, Cassibba V, Mattei D, Romani C, Cortelezzi A, Corti C, Scattolin AM, Spinelli O, Tosi M, Parolini M, Marmont F, Borlenghi E, Fumagalli M, Cortelazzo S, Gallamini A, Marfisi RM, Oldani E, Rambaldi A.

Haematologica. 2015 Jun;100(6):786-93. doi: 10.3324/haematol.2014.123273.

6.

What is the healing time of Stage II pressure ulcers? Findings from a secondary analysis.

Palese A, Luisa S, Ilenia P, Laquintana D, Stinco G, Di Giulio P; PARI-ETLD Group..

Adv Skin Wound Care. 2015 Feb;28(2):69-75. doi: 10.1097/01.ASW.0000459964.49436.ce.

PMID:
25608012
7.

Should patients perception of health status be integrated in the prognostic assessment of heart failure patients? A prospective study.

Network of Nurses of GISSI-HF., Di Giulio P.

Qual Life Res. 2014 Feb;23(1):49-56. doi: 10.1007/s11136-013-0468-8.

PMID:
23912852
8.

n-3 fatty acids in patients with multiple cardiovascular risk factors.

Risk and Prevention Study Collaborative Group..

N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. Erratum in: N Engl J Med. 2013 May 30;368(22):2146.

9.

Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.

Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R.

Am Heart J. 2013 Feb;165(2):208-15.e4. doi: 10.1016/j.ahj.2012.10.021.

PMID:
23351824
10.

Cardiovascular events and intensity of treatment in polycythemia vera.

Marchioli R, Finazzi G, Specchia G, Cacciola R, Cavazzina R, Cilloni D, De Stefano V, Elli E, Iurlo A, Latagliata R, Lunghi F, Lunghi M, Marfisi RM, Musto P, Masciulli A, Musolino C, Cascavilla N, Quarta G, Randi ML, Rapezzi D, Ruggeri M, Rumi E, Scortechini AR, Santini S, Scarano M, Siragusa S, Spadea A, Tieghi A, Angelucci E, Visani G, Vannucchi AM, Barbui T; CYTO-PV Collaborative Group..

N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500.

11.

Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction.

Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R.

Int J Cardiol. 2013 Jul 15;167(1):262-9. doi: 10.1016/j.ijcard.2011.12.110.

PMID:
22261690
13.

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I.

Lancet. 2010 Feb 27;375(9716):735-42. doi: 10.1016/S0140-6736(09)61965-6.

PMID:
20167359
14.

Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.

Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, Maggioni AP, Nicolosi GL, Scarano M, Silletta MG, Schweiger C, Tavazzi L, Tognoni G.

J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7.

PMID:
17876196
15.

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.

Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisloff F, Marziali S, Morboeuf O, Barbui T.

Blood. 2007 Aug 15;110(4):1178-83.

16.

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, Marfisi RM, Finazzi G, Guerini V, Fabris F, Randi ML, De Stefano V, Caberlon S, Tafuri A, Ruggeri M, Specchia G, Liso V, Rossi E, Pogliani E, Gugliotta L, Bosi A, Barbui T.

Blood. 2007 Aug 1;110(3):840-6.

17.

High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.

Avanzini F, Alli C, Boccanelli A, Chieffo C, Franzosi MG, Geraci E, Maggioni AP, Marfisi RM, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R; GISSI-Prevenzione investigators..

J Hypertens. 2006 Dec;24(12):2377-85.

PMID:
17082719
18.

Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.

Marchioli R, Levantesi G, Macchia A, Marfisi RM, Nicolosi GL, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators..

J Cardiovasc Med (Hagerstown). 2006 May;7(5):347-50.

PMID:
16645413
19.

Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.

Marchioli R, Levantesi G, Macchia A, Maggioni AP, Marfisi RM, Silletta MG, Tavazzi L, Tognoni G, Valagussa F; GISSI-Prevenzione Investigators..

J Membr Biol. 2005 Jul;206(2):117-28.

PMID:
16456722
20.

Analysis of the benefits of a Mediterranean diet in the GISSI-Prevenzione study: a case study in imputation of missing values from repeated measurements.

Barzi F, Woodward M, Marfisi RM, Tognoni G, Marchioli R; GISSI-Prevenzione Investigators..

Eur J Epidemiol. 2006;21(1):15-24.

PMID:
16450202
Items per page

Supplemental Content

Loading ...
Support Center